Veeva Systems Inc. (LON:0LO3)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 32.94B |
| Revenue (ttm) | 2.24B |
| Net Income (ttm) | 612.48M |
| Shares Out | n/a |
| EPS (ttm) | 3.68 |
| PE Ratio | 53.78 |
| Forward PE | 33.13 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,842 |
| Average Volume | 432 |
| Open | 283.00 |
| Previous Close | 294.89 |
| Day's Range | 273.68 - 286.27 |
| 52-Week Range | 198.24 - 298.69 |
| Beta | n/a |
| RSI | 46.36 |
| Earnings Date | Aug 27, 2025 |
About Veeva Systems
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides ... [Read more]
Financial Performance
In 2024, Veeva Systems's revenue was $2.75 billion, an increase of 16.20% compared to the previous year's $2.36 billion. Earnings were $714.14 million, an increase of 35.84%.
Financial numbers in USD Financial StatementsNews
What to Expect from Veeva Sys's Earnings
Veeva Sys (NYSE: VEEV) is preparing to release its quarterly earnings on Wednesday, 2025-08-27. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...
Here's How Much $1000 Invested In Veeva Systems 10 Years Ago Would Be Worth Today
Veeva Systems (NYSE: VEEV) has outperformed the market over the past 10 years by 15.78% on an annualized basis producing an average annual return of 28.25%. Currently, Veeva Systems has a market capi...
Leaders Come Together to Advance the Industry at Veeva Summit
Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction Veeva to showcase innovations, including de...
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
RESEARCH TRIANGLE PARK, N.C. & PLEASANTON, Calif.--(BUSINESS WIRE)--IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and the complete resolu...
The old software investing playbook is dead. Here's where to put your money now.
Software companies are facing a reckoning as AI lowers barriers to entry. Experts share how to find winners in an evolving competitive landscape.
Research Shows Medtechs Prioritizing Site Collaboration and Data Quality
Nearly 70% say reducing manual processes is a key priority for working with sites PLEASANTON, Calif. , Aug. 12, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced findings from the 2025 V...
Veeva to Release Fiscal 2026 Second Quarter Results on August 27, 2025
PLEASANTON, Calif. , Aug. 6, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its second quarter, which ended July 31, 2025, after market close on August 27, 2025.
AI Stock With Unique Focus Joins Palantir, Nvidia On 3 Elite Lists
As top funds bet big on AI stocks Nvidia and Palantir, they also scooped up Veeva stock as it teases a breakout.
Survey Finds Medtechs Lack Confidence in Regulatory Data Quality
Veeva MedTech report reveals opportunity to move beyond manual processes for speed and compliance PLEASANTON, Calif. , July 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced findings...
Novotech Awarded Veeva Hero Award at 2025 Veeva R&D and Quality Summit
SYDNEY--(BUSINESS WIRE)-- #Novotech--Novotech, a globally recognized full-service clinical research organization (CRO), is proud to announce that we have received the highly regarded Veeva Hero award ...
Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today
Veeva Systems (NYSE: VEEV) has outperformed the market over the past 10 years by 15.19% on an annualized basis producing an average annual return of 26.84%. Currently, Veeva Systems has a market capi...
The Big 3: ANET, HSY, VEEV
Dan Deming turns to two rising tech names and an ol' reliable in consumer staples for today's Big 3. He talks about the opportunity on weakness for Arista Networks (ANET), changes to note in Veeva Sys...
Veeva OpenData and Veeva Network Enable Coordinated Customer Engagement for Boehringer Ingelheim
PLEASANTON, Calif. , July 23, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than 100 coun...
Veeva Systems Breaks Up With Salesforce, Then Woos Merck
This software stock is nearing the buy point of a newly formed flat base. Here's how Merck is expanding its long-term partnership with Veeva Systems.
Merck Commits to Veeva Vault CRM
Deep application provides foundation for commercial execution PLEASANTON, Calif. , July 21, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Merck (NYSE: MRK), known as MSD outside...
Veeva Systems: A Strong Contender in Cloud Computing for Pharma
Veeva Systems: Growth Momentum Remains Strong
Veeva Systems: Solid Performance, Terrible Price
$100 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today
Veeva Systems (NYSE: VEEV) has outperformed the market over the past 10 years by 14.29% on an annualized basis producing an average annual return of 25.84%. Currently, Veeva Systems has a market capi...
Veeva expands 10-year relationship with AWS
Veeva and AWS Expand 10-Year Relationship
PLEASANTON, Calif. & SEATTLE--(BUSINESS WIRE)--Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), and Veeva Systems (NYSE: VEEV), a leading provider of software, data, and bu...
Veeva's Rally Could Be A Bull Trap - A Prolonged Consolidation Looms
Veeva Systems VEEV is currently in its 17th Phase of the 18-phase Adhishthana Cycle, and despite what may appear as bullish structure on the weekly charts, the best move for investors right now is to ...
Veeva's Rally Could Be A Bull Trap - A Prolonged Consolidation Looms
Veeva Systems (NASDAQ: VEEV) is currently in its 17th Phase of the 18-phase Adhishthana Cycle, and despite what may appear as bullish structure on the weekly charts, the best move for investors right...
Veeva Systems: The Strong Quarter May Be A First Of Many To Come
Medtech Industry Establishes Foundation for Clinical Trials with Veeva MedTech
More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speed PLEASANTON, Calif. , June 11, 2025 /PRNewswire/ -- Veeva Systems (...